Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Is The Antipyretic Drugs For Children Market Expected To Grow In Terms Of Size?

There’s been a significant growth in the market size for pediatric antipyretic drugs in the recent past. The market, which was valued at $3.21 billion in 2024, is projected to increase to $3.4 billion in 2025, with a compound annual growth rate (CAGR) of 5.9%. The uptick in growth during the historic period can be linked to factors such as the heightened awareness of child health, causing a surge in demand for antipyretic drugs, the global increase in fever-related illnesses among children, and the escalation in healthcare spending by families on common fevers in children. Other contributing factors are the enhanced access to over-the-counter antipyretic drugs in growing economies and an amplifying focus on preventive healthcare and early fever treatment in children.

The market size of antipyretic drugs for children is predicted to witness significant growth in the coming years. The value is projected to reach “$4.34 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.3%. The anticipated growth during this period can be credited to the increased emphasis on improvements in pediatric healthcare, which boost the requirement for safer antipyretic drugs. Furthermore, the escalating occurrence of viral infections among children is escalating the demand for antipyretic treatments. Other contributions include novel advancements in drug formulations and delivery mechanisms enhancing the effectiveness of antipyretics, the expansion of pharmaceutical entities in burgeoning markets enhancing the supply of pediatric medications, and growing government initiatives working towards improving access to pediatric healthcare in developing nations. Several trends set to influence the forecast period include technological innovation in pediatric drug formulation for swift and safer fever management, a tendency towards using natural and herbal-based antipyretic drugs for children, increasing importance placed on personalizing pediatric treatments for fever management, the rising use of telemedicine platforms for pediatric consultation related to fever management, and the development of combined drugs to treat multiple symptoms in children.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18956&type=smp

Which Demand Drivers Are Strengthening The Antipyretic Drugs For Children Market?

The anticipated surge in the antipyretic drugs for children market can be attributed to a rising number of bacterial and viral infections. Viral infections, which are diseases like flu or influenza, occur when viruses invade and reproduce within host cells. On the other hand, illnesses such as strep throat and tuberculosis are the result of harmful bacteria entering and proliferating in the body. The escalating rate of these bacterial and viral infections is linked to growing antibiotic resistance, increased global travel, and high population density, which accelerate the transmission of pathogens. Children are given antipyretic drugs like acetaminophen or ibuprofen to lower fever and alleviate discomfort resulting from these infections. Case in point, The Office for National Statistics, a non-ministerial department in the UK, reported in May 2022 that from December 2021 to March 2022, flu and pneumonia caused 6,898 deaths in the UK, marking an increase from the 5,288 deaths in the same period in 2020-2021, which means over 1,600 more deaths year-over-year. Thus, the increasing rate of bacterial and viral infections is fuelling the growth of the antipyretic drugs for children market.

What Are The Key Segment Trends Observed In The Antipyretic Drugs For Children Market?

The antipyretic drugs for children market covered in this report is segmented –

1) By Drug Class: Acetaminophen, Ibuprofen, Other Drug Classes

2) By Dosage Form: Tablets, Syrups, Suppositories, Other Dosage Forms

3) By Age Group: Newborns, Infants, Toddlers, Children

Subsegments:

1) By Acetaminophen: Oral Suspension, Chewable Tablets, Suppositories

2) By Ibuprofen: Oral Suspension, Chewable Tablets, Suppositories

3) By Other Drug Classes: Aspirin, Naproxen

Which Disruptive Trends Are Driving Change Across The Antipyretic Drugs For Children Market?

Leading companies in the antipyretic drugs for children market are concentrating on the development of innovative drug formulations, such as medicine gummy bites, to augment ease of ingestion and boost adherence among young patients. Medicinal gummy bites are chewable, gummy-like medications designed to make the task of medicine intake more attractive, particularly for children. They are available in different shapes and tastes to facilitate better adherence and simplify the regimen. For instance, in October 2023, an acetaminophen gummy bite was introduced by DrKids, a pharmaceutical firm based in the US. This inventive medicinal solution provides a kid-friendly option for pain and fever management. It incorporates a precise dosing system making the job of medicine administration simpler for parents while ensuring safety and efficacy.

Which Firms Are Driving Innovation Within The Antipyretic Drugs For Children Market?

Major companies operating in the antipyretic drugs for children market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol Myers Squibb, GlaxoSmithKline plc, Reckitt Benckiser Group, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Lupin Limited, Towa Pharmaceutical Co Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Limited

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/antipyretic-drugs-for-children-global-market-report

What Regional Factors Are Accelerating Growth In The Antipyretic Drugs For Children Market?

North America was the largest region in the antipyretic drugs for children market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antipyretic drugs for children market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=18956&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model